Cargando…
Immunotherapy in hepatocellular carcinoma: how will it reshape treatment sequencing?
The treatment landscape of advanced hepatocellular carcinoma (HCC) has broadened with immune checkpoint inhibitors (ICIs) setting a novel standard of care. With the increased number of therapies either in first or in further line, disentangling the possible treatment sequences has become much more c...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837292/ https://www.ncbi.nlm.nih.gov/pubmed/36643654 http://dx.doi.org/10.1177/17588359221148029 |